Conduit Pharmaceuticals Inc. has announced a strategic services agreement with Agility Life Sciences to develop new solid oral-dosage form products for its autoimmune pipeline, intended for future ...
Recently, a CEO I know (I’ll call him Jeff) invited me to weigh in on a corporate strategy initiative that his company was undertaking. Jeff and his leadership team had been focused on day-to-day ...
On Wednesday, 19 November 2025, at the Jefferies London Healthcare Conference 2025, Viking Therapeutics (NASDAQ:VKTX) presented a comprehensive update on its clinical programs. The company showcased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback